Viewing Study NCT01888432

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2026-03-11 @ 4:15 AM
Study NCT ID: NCT01888432
Status: COMPLETED
Last Update Posted: 2019-03-18
First Post: 2013-06-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Liver Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None liver transplantation View
None everolimus View
None tacrolimus View
None reduced calcineuron inhibitor View
None renal function View
None living donor View
None RAD001H2307 View
None RAD001H View